Bulletin
Investor Alert

Harrow Health Inc.

NAS: HROW

GO
/marketstate/country/us

Market closed

 --Quotes are delayed by 20 min

Oct 25, 2021, 4:00 p.m.

/zigman2/quotes/206805265/composite

$

9.69

Change

-0.05 -0.51%

Volume

Volume 47,376

Quotes are delayed by 20 min

/zigman2/quotes/206805265/composite

Previous close

$ 9.74

$ 9.69

Change

-0.05 -0.51%

Day low

Day high

$9.57

$10.04

Open

52 week low

52 week high

$4.65

$11.24

Open

Annual Financials for Harrow Health Inc.

Fiscal year is January-December. All values USD millions. 20162017201820192020 5-year trend
Sales/Revenue 19.94M26.77M41.37M51.17M48.87M
Cost of Goods Sold (COGS) incl. D&A 9.83M13.51M16.52M16.75M14.46M
COGS excluding D&A 8.43M11.74M14.68M14.09M11.72M
Depreciation & Amortization Expense 1.41M1.77M1.84M2.66M2.74M
Depreciation 1.06M1.4M1.61M2.45M2.58M
Amortization of Intangibles 351,000364,000235,000209,000167,000
Gross Income 10.11M13.27M24.85M34.42M34.41M
20162017201820192020 5-year trend
SG&A Expense 25.69M25.43M30.07M34.69M34.32M
Research & Development 739,000413,000825,0002.08M3.07M
Other SG&A 24.95M25.02M29.24M32.61M31.25M
Other Operating Expense -----
Unusual Expense 2.61M1.24M393,0004.52M359,000
EBIT after Unusual Expense (18.19M)(1.24M)(5.61M)(4.52M)(270,000)
Non Operating Income/Expense 1.77M-5.42M6.44M(77,000)
Non-Operating Interest Income 10,000----
Equity in Affiliates (Pretax) -3.51M17.54M738,000(1.49M)
Interest Expense 2.78M3.03M2.73M2.5M2.24M
Gross Interest Expense 2.78M3.03M2.73M2.5M2.24M
Interest Capitalized -----
Pretax Income (19.2M)(12.92M)14.63M(117,000)(4.07M)
Income Tax (111,000)(935,000)-8,000(655,000)
Income Tax - Current Domestic 8,000--8,0004,000
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic (119,000)----
Income Tax - Deferred Foreign -----
Income Tax Credits ----659,000
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income (19.09M)(11.99M)14.63M(125,000)(3.42M)
Minority Interest Expense ---(293,000)(62,000)
Net Income (19.09M)(11.99M)14.63M168,000(3.36M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries (19.09M)(11.99M)14.63M168,000(3.36M)
Preferred Dividends -----
Net Income Available to Common (19.09M)(11.99M)14.63M168,000(3.36M)
EPS (Basic) (1.50)(0.60)0.670.01(0.13)
Basic Shares Outstanding 12.74M20.03M21.92M25.32M25.9M
EPS (Diluted) (1.50)(0.60)0.610.01(0.13)
Diluted Shares Outstanding 12.74M20.03M23.81M26.47M25.9M
EBITDA (14.17M)(10.4M)(3.37M)2.39M2.83M
Trending Tickers
  • /zigman2/quotes/200467500/composite NVDA+6.01%
  • /zigman2/quotes/200164174/composite SNOA+85.40%
  • /zigman2/quotes/202092269/composite ENSC+35.46%
  • /zigman2/quotes/226465160/composite ALF-14.72%
  • /zigman2/quotes/207732364/composite MSFT+1.66%
X
Powered by StockTwits
Link to MarketWatch's Slice.